Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.
Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. Given a possible role for dysregulation of iron metabolism in MS disease pathogenesis, we investigated whether or not mutations in the HFE gene influence the pro...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|
| _version_ | 1797095502227963904 |
|---|---|
| author | Ramagopalan, S Cukjati, M Cernilec, M DeLuca, G Dyment, D Degenhardt, A Sadovnick, A Serbec, VC Ebers, G Duquette, P |
| author_facet | Ramagopalan, S Cukjati, M Cernilec, M DeLuca, G Dyment, D Degenhardt, A Sadovnick, A Serbec, VC Ebers, G Duquette, P |
| author_sort | Ramagopalan, S |
| collection | OXFORD |
| description | Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. Given a possible role for dysregulation of iron metabolism in MS disease pathogenesis, we investigated whether or not mutations in the HFE gene influence the prognosis of the disease. A cohort of sporadic MS cases, taken from opposite extremes of the putative distribution of long-term outcome using the most stringent clinical criteria to date, was used to determine the role of HFE on MS disease severity. This approach increases the effective sample size by some 40-fold. Genotyping the two sets of MS patients (112 benign and 51 malignant) provided no evidence to suggest that mutations in HFE have any outcome modifying activity, although small effects cannot be ruled out. The frequency of HFE mutations was not different in MS compared to the general population. |
| first_indexed | 2024-03-07T04:28:45Z |
| format | Journal article |
| id | oxford-uuid:cd93649f-2300-49ac-bcda-f4419586943d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:28:45Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:cd93649f-2300-49ac-bcda-f4419586943d2022-03-27T07:29:36ZMutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cd93649f-2300-49ac-bcda-f4419586943dEnglishSymplectic Elements at Oxford2008Ramagopalan, SCukjati, MCernilec, MDeLuca, GDyment, DDegenhardt, ASadovnick, ASerbec, VCEbers, GDuquette, PMultiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. Given a possible role for dysregulation of iron metabolism in MS disease pathogenesis, we investigated whether or not mutations in the HFE gene influence the prognosis of the disease. A cohort of sporadic MS cases, taken from opposite extremes of the putative distribution of long-term outcome using the most stringent clinical criteria to date, was used to determine the role of HFE on MS disease severity. This approach increases the effective sample size by some 40-fold. Genotyping the two sets of MS patients (112 benign and 51 malignant) provided no evidence to suggest that mutations in HFE have any outcome modifying activity, although small effects cannot be ruled out. The frequency of HFE mutations was not different in MS compared to the general population. |
| spellingShingle | Ramagopalan, S Cukjati, M Cernilec, M DeLuca, G Dyment, D Degenhardt, A Sadovnick, A Serbec, VC Ebers, G Duquette, P Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. |
| title | Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. |
| title_full | Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. |
| title_fullStr | Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. |
| title_full_unstemmed | Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. |
| title_short | Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. |
| title_sort | mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis |
| work_keys_str_mv | AT ramagopalans mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT cukjatim mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT cernilecm mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT delucag mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT dymentd mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT degenhardta mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT sadovnicka mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT serbecvc mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT ebersg mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis AT duquettep mutationsinthehemochromatosisgeneandtheclinicaloutcomeofmultiplesclerosis |